Capitalising on Peter Mac's unique expertise in all pathology disciplines to deliver oncology laboratory assays including novel tests and technologies, nexomics was established in 2016 to support clinical trials and medical testing. Our dedicated state-of-the-art laboratories are located at the Victorian Comprehensive Cancer Centre, one of the world’s leading cancer research, education and treatment centres globally and Australia’s only public hospital solely dedicated to caring for people affected by cancer. In the past 10 years our team has delivered 1000+ clinical studies from Phases I to IV in all major oncology indications. Our unique lab-to-bedside genomics model supports the implementation of novel tests and technologies. Nexomics’s extensive capabilities, combined with our clinical and scientific expertise ensure we can serve as a key partner in cancer research programs. Our team is comprised of medical, scientific and commercialisation experts in all pathology disciplines. We are driven to transform cancer diagnostics, leading in scientific discoveries and delivering cutting edge services. Clinical Testing: Nexomics is an expert contract service provider offering oncology laboratory assays to support clinical trials and medical testing. Molecular Cancer Genomics: Nexomics offers state-of-the-art molecular services on multiple high-throughput test platforms that can interrogate RNA, DNA, ctDNA and protein from a large number of samples simultaneously.We provide clinicians with a personalised and user friendly reporting that outlines the genomic findings and patient treatment options. In the past 10 years our team has delivered 1000+ clinical studies from Phases I to IV in all major oncology indications.
